Vaxcyte Inc (NASDAQ:PCVX) price on Wednesday, April 30, rose 3.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $35.84.
A look at the stock’s price movement, the close in the last trading session was $34.77, moving within a range at $34.0717 and $36.25. The beta value (5-Year monthly) was 1.264. Turning to its 52-week performance, $121.06 and $27.66 were the 52-week high and 52-week low respectively. Overall, PCVX moved -5.08% over the past month.
Vaxcyte Inc’s market cap currently stands at around $4.62 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PCVX is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend PCVX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PCVX’s current price about 12.64% and -35.77% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.43, while 7-day volatility ratio is 6.20% and 9.48% in the 30-day chart. Further, Vaxcyte Inc (PCVX) has a beta value of 1.28, and an average true range (ATR) of 3.33. Analysts have given the company’s stock an average 52-week price target of $140.5, forecast between a low of $135 and high of $146. Looking at the price targets, the low is -276.67% off current price level while to achieve the yearly target high, price needs to move -307.37%. Nonetheless, investors will most likely welcome a -292.02% jump to $140.5 which is the analysts’ median price.
If we refocus on Vaxcyte Inc (NASDAQ:PCVX), historical trading data shows that trading volumes averaged 1.6 over the past 10 days and 2.00 million over the past 3 months. The company’s latest data on shares outstanding shows there are 128.76 million shares.
The 2.89% of Vaxcyte Inc’s shares are in the hands of company insiders while institutional holders own 108.15% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.34 million on 2025-04-15, giving us a short ratio of 3.65. The data shows that as of 2025-04-15 short interest in Vaxcyte Inc (PCVX) stood at 1083.0 of shares outstanding, with shares short falling to 12.61 million registered in 2025-03-14. Current price change has pushed the stock -56.22% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PCVX stock continues to rise going into the next quarter.
